Clinical Trial Update: S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial S0408 evaluating capecitabine, oxaliplatin, and bevacizumab in patients undergoing surgery for liver metastases from colorectal cancer was withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine) (capecitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: WITHDRAWN